Doxorubicin Active Not Recruiting Phase 3 Trials for Childhood B Acute Lymphoblastic Leukemia / Childhood B Lymphoblastic Lymphoma / Ann Arbor Stage I B Lymphoblastic Lymphoma / Acute Lymphoblastic Leukaemias (ALL) / Untreated Adult Acute Lymphoblastic Leukemia / Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1 / Intrachromosomal Amplification of Chromosome 21 / Adult B Lymphoblastic Lymphoma / Stage II B Lymphoblastic Lymphoma / Philadelphia Chromosome Positive / Stage I B Lymphoblastic Lymphoma / Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 / Ann Arbor Stage II B Lymphoblastic Lymphoma / Down Syndrome (DS) / Untreated Childhood Acute Lymphoblastic Leukemia / Hypodiploid B Acute Lymphoblastic Leukemia Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01190930Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma
NCT00549848Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia